Vantage logo

Boston Scientific’s next move

The cardiovascular specialist needs to buy its way to growth – and it has marked an interest in a handful of smaller companies.

Vantage logo

March medtech merger madness

High asset prices and a need to release the pandemic’s brake on growth force medtechs to splash the cash.